Your browser doesn't support javascript.
loading
An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology.
Jin, Runze; Zhao, Zitong; Zhang, Qing; Sun, Y U; Wang, Wei; Peng, Daiyin; Nian, Sihui; Zhou, Lingyun.
Affiliation
  • Jin R; School of Pharmacy, Wannan Medicinal College.
  • Zhao Z; School of Pharmacy, Wannan Medicinal College.
  • Zhang Q; School of Pharmacy, Wannan Medicinal College.
  • Sun YU; School of Pharmacy, Wannan Medicinal College; Provincial Engineering Laboratory for Screening and Reevaluation of Active Compounds of Herbal Medicines in Southern Anhui; Anhui Innovative Center for Drug Basic Research of Metabolic Diseases, Wannan Medical College, Wuhu.
  • Wang W; School of Pharmacy, Wannan Medicinal College.
  • Peng D; School of Pharmacy, Anhui University of Chinese Medicine; Synergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement; Anhui Province Key Laboratory of Chinese Medicinal Formula, Hefei, China.
  • Nian S; School of Pharmacy, Wannan Medicinal College; Provincial Engineering Laboratory for Screening and Reevaluation of Active Compounds of Herbal Medicines in Southern Anhui; Anhui Innovative Center for Drug Basic Research of Metabolic Diseases, Wannan Medical College, Wuhu.
  • Zhou L; School of Pharmacy, Wannan Medicinal College; Provincial Engineering Laboratory for Screening and Reevaluation of Active Compounds of Herbal Medicines in Southern Anhui; Anhui Innovative Center for Drug Basic Research of Metabolic Diseases, Wannan Medical College, Wuhu.
Pharmazie ; 79(3): 72-81, 2024 May 15.
Article in En | MEDLINE | ID: mdl-38872267
ABSTRACT
Hyperuricemia (HUA) is a disorder of uric acid metabolism, which can lead to the formation of gouty arthritis, kidney inflammation and other damages. Previous studies have found that the alcohol extract of Poria cutis can reduce the level of uric acid and protect against kidney injury. Based on network pharmacology, the core targets and main active components of P. cutis intervention in HUA were determined. Most of the potential active ingredients are triterpenoid acids such as tumulosic acid (TA) and eburicoic acid (EA), and the potential targets are TNF and IL-6, which are associated with inflammation. In vitro experiments have shown that TA can significantly inhibit the release of NO, TNF-α and IL-6 in inflammatory RAW264.7 cell culture medium and the expression of TNF-α and IL-6 in RAW264.7 cells. This study suggests that TA based on network pharmacological screening has obvious anti-inflammatory effect on inflammatory RAW264.7 cells and is a promising anti-inflammatory compound.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Tumor Necrosis Factor-alpha / Wolfiporia / Network Pharmacology / Anti-Inflammatory Agents / Nitric Oxide Limits: Animals Language: En Journal: Pharmazie Journal subject: FARMACIA Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Tumor Necrosis Factor-alpha / Wolfiporia / Network Pharmacology / Anti-Inflammatory Agents / Nitric Oxide Limits: Animals Language: En Journal: Pharmazie Journal subject: FARMACIA Year: 2024 Type: Article